These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27112703)

  • 1. Diagnostic difficulties of factor XI deficiencies: interferences' assay or real deficit?
    Gaymard A; Nougier C
    Ann Biol Clin (Paris); 2016 Jun; 74(3):341-7. PubMed ID: 27112703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.
    Livnat T; Zivelin A; Tamarin I; Guetta V; Salomon O
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):661-6. PubMed ID: 19730246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolated increased aPTT with anamnestic hemorrhagic diathesis--severe FXI deficiency].
    Redondo M; Solenthaler M; Zeerleder S; Wuillemin WA
    Ther Umsch; 1999 Sep; 56(9):502-4. PubMed ID: 10517119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.
    Livnat T; Shenkman B; Martinowitz U; Zivelin A; Dardik R; Tamarin I; Mansharov R; Budnik I; Salomon O
    Thromb Res; 2015 Aug; 136(2):465-73. PubMed ID: 26160656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant.
    Rabichow L; Dinh J; Nguyen L; Qiao J
    Blood Coagul Fibrinolysis; 2024 Jun; 35(4):217-222. PubMed ID: 38358905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies.
    Bowyer A; Kitchen S; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):154-8. PubMed ID: 20840376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired factor XI deficiency in systemic lupus erythematosus.
    Vercellotti GM; Mosher DF
    Thromb Haemost; 1982 Dec; 48(3):250-2. PubMed ID: 7164014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor XI deficiency: do patients with hemorrhagic diathesis also have hemostasis defects?].
    Peter MK; Meili EO; von Felten A
    Schweiz Med Wochenschr; 1996 Jun; 126(23):999-1005. PubMed ID: 8701241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.
    Mani H; Hesse C; Stratmann G; Lindhoff-Last E
    Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XI deficiency and hemostasis.
    Colman RW; Rao AK; Rubin RN
    Am J Hematol; 1994 Jan; 45(1):73-8. PubMed ID: 8086008
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.
    Rugeri L; Quélin F; Chatard B; De Mazancourt P; Negrier C; Dargaud Y
    Haemophilia; 2010 Sep; 16(5):771-7. PubMed ID: 20398070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
    Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
    Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative monitoring of blood coagulation in urologic operations: diagnosis of familial factor XI deficiency within the scope of preoperative blood coagulation studies].
    Haushofer A; Halbmayer WM; Toth E; Pflüger H
    Wien Med Wochenschr; 1993; 143(5):99-105. PubMed ID: 8511905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenging hemostasis scenarios in pediatric patients--two case studies.
    Moser KA; Puetz J
    Int J Lab Hematol; 2015 May; 37 Suppl 1():72-7. PubMed ID: 25976963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies.
    Ma L; Sun P; Lin F; Diao G; Li C
    Thromb Res; 2013 Sep; 132(3):381-5. PubMed ID: 23953595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor XI deficiency: actuality and review of the literature].
    Demoy M; Labrousse J; Grand F; Moyrand S; Tuffigo M; Lamarche S; Macchi L
    Ann Biol Clin (Paris); 2024 Jun; 82(2):225-236. PubMed ID: 38702892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of factor XI activity testing in North American Specialized Coagulation Laboratories.
    Zantek ND; Hsu P; Meijer P; Smock KJ; Plumhoff EA; Refaai MA; Van Cott EM
    Int J Lab Hematol; 2015 May; 37 Suppl 1():99-107. PubMed ID: 25976967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global coagulation tests to assess the value of the presurgical treatment in a patient with congenital factor XI deficiency and inhibitor.
    Biguzzi E; Siboni SM; Clerici M; Padovan L; Scalambrino E; Chantarangkul V; Novembrino C; Tripodi A
    Int J Lab Hematol; 2020 Apr; 42(2):e68-e70. PubMed ID: 31693301
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency.
    Salloum-Asfar S; de la Morena-Barrio ME; Esteban J; Miñano A; Aroca C; Vicente V; Roldán V; Corral J
    Thromb Res; 2018 Mar; 163():64-70. PubMed ID: 29367083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.